Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
It remains in Phase 3 clinical trials with regulatory submissions expected after trials complete in 2026 and potential approval in 2027
At the end of the study, the hormone therapy group lost around 19% of their body weight compared to 14% for the no HRT group
10.1111/j.1365-3059.2008.02015.x 131 RajasekharV
Patients likely will find that their appetite increases
Whilst fatigue during retatrutide treatment is commonly expected and usually resolves with time, there are specific circumstances in which it is important to seek prompt medical advice
US$ 26.16
US$ 23.06
US$ 25.72
US$ 24.96
US$ 21.58
US$ 22.71
US$ 26.35
US$ 25.32
